KORU Medical Systems, Inc.

Informe acción NasdaqCM:KRMD

Capitalización de mercado: US$96.9m

Salud financiera de hoja de balance de KORU Medical Systems

Salud financiera controles de criterios 5/6

KORU Medical Systems tiene unos fondos propios totales de $27.4M y una deuda total de $466.0K, lo que sitúa su ratio deuda/fondos propios en 1.7%. Sus activos y pasivos totales son $35.4M y $7.9M respectivamente.

Información clave

1.5%

Ratio deuda-patrimonio

US$314.34k

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$11.48m
PatrimonioUS$20.35m
Total pasivoUS$8.11m
Activos totalesUS$28.46m

Actualizaciones recientes sobre salud financiera

Recent updates

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

Feb 15
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Sep 21
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

Jul 14
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Sep 27
We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Oct 27
Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Aug 14
Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Jan 27
Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

KORU Medical Systems: A Razor & Razor Blade Story

Jan 11

Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Dec 29
Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

Dec 03
Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Dec 03
The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Repro Med Systems: Fair View Of The Fundamentals

Nov 18

Repro Med Systems, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 05

Repro Med Systems EPS misses by $0.01, misses on revenue

Nov 03

Análisis de la situación financiera

Pasivos a corto plazo: KRMDLos activos a corto plazo ($21.7M) de la empresa superan a sus pasivos a corto plazo ($4.2M).

Pasivo a largo plazo: KRMDLos activos a corto plazo ($21.7M) superan a sus pasivos a largo plazo ($3.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: KRMD tiene más efectivo que su deuda total.

Reducción de la deuda: KRMDha pasado de 0% a 1.7% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: KRMD tiene suficiente margen de tesorería para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: KRMD dispone de suficiente liquidez para 1.7 años si el flujo de caja libre sigue reduciéndose al ritmo histórico de 52.6% cada año.


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target